Alumis

ALMSNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$3.519 B

$27.60 -0.72%

Close of 7 Aug 2026

Revenue

$24.1M

#2949 by revenue

Earnings

-$243.3M

Loss-making

Shares outstanding

125,050,645

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#74IDEAYA BiosciencesIDYA$3.57B
#75Organon & Co.OGN$3.57B
#76AlumisALMS$3.52B
#77NewAmsterdam PharmaNAMS$3.34B
#78Vicore Pharma Holding ABVCRE$3.33B

Where these numbers come from

Share counts and financials for Alumis are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.